InMed Pharmaceuticals (INM) Other Working Capital Changes (2019 - 2026)
InMed Pharmaceuticals has reported Other Working Capital Changes over the past 5 years, most recently at $444462.0 for Q4 2025.
- For Q4 2025, Other Working Capital Changes rose 62.96% year-over-year to $444462.0; the TTM value through Dec 2025 reached -$3167.0, down 100.93%, while the annual FY2025 figure was -$173980.0, 757.72% down from the prior year.
- Other Working Capital Changes for Q4 2025 was $444462.0 at InMed Pharmaceuticals, up from -$107412.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $637658.0 in Q4 2021 and troughed at -$634410.0 in Q3 2021.
- A 5-year average of -$16051.7 and a median of -$12536.5 in 2022 define the central range for Other Working Capital Changes.
- Biggest five-year swings in Other Working Capital Changes: crashed 65268.16% in 2023 and later surged 254.15% in 2024.
- Year by year, Other Working Capital Changes stood at $637658.0 in 2021, then plummeted by 99.93% to $471.0 in 2022, then tumbled by 37666.45% to -$176938.0 in 2023, then surged by 254.15% to $272743.0 in 2024, then soared by 62.96% to $444462.0 in 2025.
- Business Quant data shows Other Working Capital Changes for INM at $444462.0 in Q4 2025, -$107412.0 in Q3 2025, and -$186125.0 in Q2 2025.